Zhang, F.; Ferrero, M.; Dong, N.; D’Auria, G.; Reyes-Prieto, M.; Herreros-Pomares, A.; Calabuig-Fariñas, S.; Duréndez, E.; Aparisi, F.; Blasco, A.;
et al. Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers 2021, 13, 2514.
https://doi.org/10.3390/cancers13112514
AMA Style
Zhang F, Ferrero M, Dong N, D’Auria G, Reyes-Prieto M, Herreros-Pomares A, Calabuig-Fariñas S, Duréndez E, Aparisi F, Blasco A,
et al. Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers. 2021; 13(11):2514.
https://doi.org/10.3390/cancers13112514
Chicago/Turabian Style
Zhang, Feiyu, Macarena Ferrero, Ning Dong, Giuseppe D’Auria, Mariana Reyes-Prieto, Alejandro Herreros-Pomares, Silvia Calabuig-Fariñas, Elena Duréndez, Francisco Aparisi, Ana Blasco,
and et al. 2021. "Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer" Cancers 13, no. 11: 2514.
https://doi.org/10.3390/cancers13112514
APA Style
Zhang, F., Ferrero, M., Dong, N., D’Auria, G., Reyes-Prieto, M., Herreros-Pomares, A., Calabuig-Fariñas, S., Duréndez, E., Aparisi, F., Blasco, A., García, C., Camps, C., Jantus-Lewintre, E., & Sirera, R.
(2021). Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers, 13(11), 2514.
https://doi.org/10.3390/cancers13112514
